We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+12.56%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
–
Cap. Flow
+$3.41B
Cap. Flow %
101.25%
Top 10 Hldgs %
50.48%
Holding
489
New
489
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$483M
2
NVDA icon
NVIDIA
NVDA
+$247M
3
AAPL icon
Apple
AAPL
+$186M
4
TSM icon
TSMC
TSM
+$179M
5
MSFT icon
Microsoft
MSFT
+$143M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 52.03%
2 Consumer Discretionary 19.21%
3 Communication Services 9.64%
4 Healthcare 4.63%
5 Consumer Staples 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
301
Becton Dickinson
BDX
$42.6B
$463K 0.01%
+2,943
New +$540K
EW icon
302
Edwards Lifesciences
EW
$48.9B
$461K 0.01%
+5,752
New +$474K
FFIV icon
303
F5
FFIV
$23.2B
$457K 0.01%
+1,581
New +$438K
PLD icon
304
Prologis
PLD
$138B
$452K 0.01%
+3,418
New +$457K
LMT icon
305
Lockheed Martin
LMT
$117B
$448K 0.01%
+742
New +$457K
SRPT icon
306
Sarepta Therapeutics
SRPT
$1.78B
$445K 0.01%
+20,453
New +$396K
JCI icon
307
Johnson Controls International
JCI
$85B
$443K 0.01%
+3,384
New +$437K
AKAM icon
308
Akamai
AKAM
$17.9B
$442K 0.01%
+3,847
New +$386K
NCLH icon
309
Norwegian Cruise Line
NCLH
$8.95B
$442K 0.01%
+23,616
New +$516K
CB icon
310
Chubb
CB
$137B
$441K 0.01%
+1,354
New +$434K
IMVT icon
311
Immunovant
IMVT
$8.2B
$440K 0.01%
+17,715
New +$459K
AGIO icon
312
Agios Pharmaceuticals
AGIO
$2.38B
$437K 0.01%
+12,915
New +$366K
RARE icon
313
Ultragenyx Pharmaceutical
RARE
$2.81B
$436K 0.01%
+20,796
New +$468K
IRON icon
314
Disc Medicine
IRON
$2.84B
$433K 0.01%
+6,772
New +$470K
IMNM icon
315
Immunome
IMNM
$2.51B
$429K 0.01%
+19,638
New +$437K
PGR icon
316
Progressive
PGR
$123B
$427K 0.01%
+2,154
New +$445K
CDW icon
317
CDW
CDW
$16.6B
$426K 0.01%
+3,523
New +$445K
A icon
318
Agilent Technologies
A
$36.8B
$426K 0.01%
+3,734
New +$474K
COF icon
319
Capital One
COF
$127B
$425K 0.01%
+2,327
New +$487K
BCRX icon
320
BioCryst Pharmaceuticals
BCRX
$2.32B
$424K 0.01%
+44,532
New +$346K
VCYT icon
321
Veracyte
VCYT
$4.57B
$422K 0.01%
+13,100
New +$485K
RMD icon
322
ResMed
RMD
$28.8B
$419K 0.01%
+1,867
New +$465K
WAT icon
323
Waters Corp
WAT
$35.1B
$418K 0.01%
+1,404
New +$480K
PH icon
324
Parker-Hannifin
PH
$120B
$418K 0.01%
+467
New +$442K
DYN icon
325
Dyne Therapeutics
DYN
$3.88B
$417K 0.01%
+23,001
New +$397K
11 12
13
14 15

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q1 2026 Portfolio in Review

Q1 2026 is the first quarter with a 13F filing on record for E Fund Management, which disclosed 489 positions worth $3.37B. Its ten largest holdings account for 50% of the portfolio.

Its largest position is Pinduoduo: 4,593,053 shares worth $469M.

By sector, the portfolio is most concentrated in Technology at 52% of assets, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q1 2026 buy was Pinduoduo: 4,593,053 shares worth $469M.
  • E Fund Management's ten largest holdings make up 50% of its $3.37B portfolio in Q1 2026.
  • E Fund Management disclosed 489 positions in Q1 2026, its first 13F filing on record.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.